To investigate the effect of intercalative ligand on their biological activity, five new complexes [Ru(bpy)(2)(dpq)](ClO4)(2) (bpy = 2,2'-bipyridine, dpq = dipyridoquinoxaline), [Ru(bpy)(2)(dicnq)](ClO4)(2) (dicnq = pyrazino[2,3-f]phenanthroline-2,3-dicarbonitrile), [Ru(bpy)(2)(dppp3)](ClO4)(2) (dppp3 = pyrido [3',4':5,6]pyrazino[2,3-f][1,10]phenanthroline), [Ru(bpy)(2)(dppp2)](ClO4)(2) (dppp2 = pyrido[2',3':5,6]pyrazino[2,3-f][1,10]phenanthroline) and [Ru(bpy)(2)(OCH3-dppz)](ClO4)(2) (OCH3-dppz = 11-methoxy-dipyrido[3,2-a:2',3'-c]phenazine) have been synthesized and characterized in detail by H-1 NMR spectroscopy, mass spectrometry and elemental analysis. Their interaction with calf thymus DNA and the inhibitory activity towards topoisomerase II and T7 RNA polymerase have been examined by a series of experimental methods. The results suggest that a high DNA-binding affinity is important for their topoisomerase II and DNA transcription inhibition. Intercalative ligands with more extended aromatic area, better conjugate effect and presence of electron-withdrawing substituted groups are beneficial to the DNA intercalation and enzymatic inhibition of their polypyridyl Ru(II) complexes. (C) 2011 Elsevier B.V. All rights reserved.